
Develpin 250mg Tablet ER
Marketer
Lifecare Innovations Pvt Ltd
Salt Composition
Valproic Acid (250mg)
Overview Develpin 250mg Tablet ER
Epileptic seizures and bipolar disorder are effectively managed with Develpin 250mg Extended-Release tablets, which also help prevent migraine attacks. This medication soothes the nervous system, promoting a calming effect on the brain. Develpin 250mg ER can be ingested with or without food, ideally at the same time daily, as prescribed by your physician. Missed doses should be taken immediately upon recall. Complete the entire course of treatment, even with symptom improvement; never discontinue abruptly. Sudden cessation may trigger increased seizure activity; consult your doctor before stopping. Potential side effects include headache, blurred vision, appetite loss, nausea, vomiting, alopecia, and diarrhea. Drowsiness and dizziness are also possible; avoid driving or activities requiring alertness until the drug's effects are known. Weight gain is a possible consequence; maintain a healthy diet and exercise to mitigate this. Report persistent or bothersome side effects to your doctor.
Uses of Develpin 250mg Tablet ER
Managing Epilepsy and Seizures | Migraine Prophylaxis | Bipolar Disorder Treatment
Major Benefits of Develpin 250mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or dividing it. Develpin 250mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Develpin 250mg Tablet ER:
- Headache
- Dizziness
- Blurred vision
- Loss of appetite
- Nausea
- Vomiting
- Sleepiness
- Hair loss
- Weight gain
- Tremors
- Double vision
- Diarrhea
- Impaired coordination
- Increased appetite
- Weakness
- Stomach pain
How to use Develpin 250mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the 250mg Develpin Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer with food.
How Develpin 250mg Tablet ER works:
Epileptic seizures are managed by Develpin 250mg Extended-Release tablets, an anticonvulsant that reduces overactive neuronal firing in the brain.
SAFETY ADVICE
AlcoholUNSAFE
Combining Develpin 250mg Extended-Release Tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Develpin 250mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Develpin 250mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Extended-release Develpin 250mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should use Develpin 250mg Extended-Release tablets cautiously, as dosage modification may be necessary. Physician consultation is advised for individuals with pre-existing kidney conditions.
LiverUNSAFE
The use of Develpin 250mg Extended-Release tablets is contraindicated in individuals with hepatic impairment; patients with severe or active liver disease should not take this medication. Physician consultation is advised.
What if you forget to take Develpin 250mg Tablet ER :
Should you forget to take a Develpin 250mg Extended-Release tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Develpin 250mg Tablet ER
| Label | Value |
|---|---|
| Chemical Classification | Valproate |
| Developing Habits | No. |
| Type of Treatment | Neuroscience Central Nervous System |
| Behavioral Class | Antiepileptic drugs targeting sodium channels |
